Abstract:Therapy on lipid metabolism is emerging as a groundbreaking cancer treatment, offering the unprecedented opportunity to effectively treat and in several cases. Tumorigenesis is inextricably linked to lipid metabolism. In this regard, the features of lipid metabolism include lipid synthesis, decomposition, metabolism and lipid storage and mobilisation from intracellular lipid droplets. Most importantly, the regulation of lipid metabolism is central to the appropriate immune response of tumour cells, and ultimately to exert the immune efforts to realise the perspective of many anti-tumour effects. Different cancers and immune cells have different dependence on lipid metabolism, playing a pivotal role in differentiation and function of immune cells. However, what lies before the immunotherapy targeting lipid metabolism is side effects of systemic toxicity and defects of individual drugs, which strongly highlights that nanodelivery strategy is a magnet for it to enhance drug efficiency, reduce drug toxicity and improve application deficiencies. This review will first focus on emerging research progress of lipid metabolic reprogramming mechanism, and then explore the complex role of lipid metabolism in the tumour cells including the effect on immune cells and their nano-preparations of monotherapy and multiple therapies used in combination, in a shift away from conventional cancer research.HighlightsThe regulation of lipid metabolism is central to the appropriate immune response of tumour cells, and ultimately to exert the immune efforts to realise the perspective of many anti-tumour effects.Preparations of focusing lipid metabolism have side effects of systemic toxicity and defects of individual drugs. It strongly highlights that nanodelivery strategy is a magnet for it to enhance drug efficiency, reduce drug toxicity and improve application deficiencies.This review will first focus on emerging research progress of lipid metabolic reprogramming mechanism, and then explore the complex role of lipid metabolism in the tumour cells including the effect on immune cells as well as their nano-preparations of monotherapy and multiple therapies used in combination, in a shift away from conventional cancer research.

Emerging targets in lipid metabolism for cancer therapy

Lipid metabolism in tumor microenvironment: novel therapeutic targets

Lipid Metabolism in Cancer Progression and Therapeutic Strategies

Lipids in the tumor microenvironment: From cancer progression to treatment

Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors

Targeting dysregulated lipid metabolism in the tumor microenvironment

Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer

Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy

The emerging role of targeting cancer metabolism for cancer therapy

Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Targeting cellular metabolism to improve cancer therapeutics

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Cancer Focus Lipid metabolism and cancer

Lipid metabolic reprogramming in cancer cells

Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy

Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat

A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells

Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy

Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy